AstraZeneca

AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biotechnology company headquartered in Cambridge, United Kingdom.

Its product portfolio includes treatments for cancer, cardiovascular disease, gastrointestinal disease, infection, neuroscience, respiratory disease, and inflammation, among other diseases. The Oxford-AstraZeneca COVID-19 vaccine is the company's most well-known product. The company has a $149 billion market cap.

The business is well-known all over the world. However, the United States and emerging markets generate the majority of the company's revenue, with Europe and the rest of the world following closely behind. More than 100 countries are served by the firm. The company operates in the majority of countries.

• Headquarters: 1 Francis Crick Avenue, Cambridge, UK
• Founded: 1999
• Market cap: $195.17 Billion
• Website: www.astrazeneca.com